Document is current
Any future updates will be listed below
-
Authors
Shimura, Masahiko https://orcid.org/0000-0001-5456-6374
Oh, Hideyasu
Ueda, Tetsuo
Kitano, Shigehiko
Mitamura, Yoshinori
Sato, Junko
Iwasaki, Keisuke
Hirakata, Akito
,
-
Funding
Funding for this research was provided by:
Chugai Pharmaceutical
F. Hoffman-La Roche Ltd.
Genentech
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 29 May 2024
First Online: 31 July 2024
Declarations
:
: M. Shimura, Consulting fees (Chugai, Roche), Lecture fees (Chugai); H. Oh, Grants (Chugai), Lecture fees (Alcon, Bayer, Kowa, Novartis, Santen); T. Ueda, Grants (Chugai), Speaker fee (Chugai); S. Kitano, Consulting fees (Chugai), Speaker fees (Bayer, Novartis); Y. Mitamura, Grants (Santen), Speaker fee (Bayer, Chugai, Novartis, Santen); J. Sato, Employee (Chugai); K. Iwasaki, Employee (Chugai); A. Hirakata, Grants (Alcon, Santen), Consulting fees (Bayer, Alcon), Speaker fees (Chugai).
: Data reported in this manuscript were presented in part at 127th Annual Meeting of the Japanese Ophthalmological Society; Tokyo, Japan; 6–9 April 2023.
